R1	Has_negation Arg1:T3 Arg2:T2	
R2	AND Arg1:T1 Arg2:T3	
*	OR T4 T6 T5 T7
*	OR T1 T9
R3	Subsumes Arg1:T1 Arg2:T4	
R4	Subsumes Arg1:T14 Arg2:T15	
R5	Has_value Arg1:T13 Arg2:T14	
R6	Subsumes Arg1:T10 Arg2:T11	
R7	Has_value Arg1:T10 Arg2:T12	
*	OR T10 T13
*	OR T18 T17
R8	Has_multiplier Arg1:T18 Arg2:T19	
R9	AND Arg1:T16 Arg2:T18	
R10	AND Arg1:T22 Arg2:T24	
*	OR T21 T23
R11	Has_qualifier Arg1:T22 Arg2:T21	
R12	AND Arg1:T29 Arg2:T26	
*	OR T27 T28
R13	Subsumes Arg1:T29 Arg2:T27	
*	OR T31 T33 T32
R14	Has_multiplier Arg1:T31 Arg2:T34	
R15	Has_temporal Arg1:T31 Arg2:T35	
R16	Has_multiplier Arg1:T37 Arg2:T38	
R17	Has_temporal Arg1:T37 Arg2:T39	
R18	Has_multiplier Arg1:T46 Arg2:T47	
*	OR T40 T41
*	OR T42 T43 T44 T45 T46
R19	AND Arg1:T40 Arg2:T42	
*	OR T50 T51 T52
R20	Has_multiplier Arg1:T50 Arg2:T53	
R21	Has_temporal Arg1:T50 Arg2:T54	
*	OR T56 T57 T58
R22	Has_multiplier Arg1:T56 Arg2:T59	
*	OR T56 T60
R23	Has_temporal Arg1:T56 Arg2:T61	
*	OR T65 T67 T66 T68
R24	Has_negation Arg1:T65 Arg2:T64	
R25	Has_qualifier Arg1:T70 Arg2:T71	
*	OR T72 T73
R26	Has_value Arg1:T72 Arg2:T74	
R27	Has_value Arg1:T73 Arg2:T75	
R28	Subsumes Arg1:T70 Arg2:T72	
T1	Condition 0 13	Renal disease
T2	Negation 14 23	unrelated
T3	Condition 27 30	SLE
T4	Condition 37 54	diabetes mellitus
T5	Condition 76 102	tubulointerstitial disease
T6	Condition 62 72;95 102	glomerular disease
T7	Condition 104 124	renovascular disease
T9	Procedure 130 149	transplanted kidney
T10	Measurement 152 188	Estimated glomerular filtration rate
T11	Measurement 190 194	eGFR
T12	Value 204 226	=20 mL/min per 1.73 m2
T13	Measurement 230 246	serum creatinine
T14	Value 247 262	>300 micromol/L
T15	Value 264 274	3.39 mg/dL
T16	Procedure 291 303	Renal biopsy
T17	Condition 324 346	fibrocellular crescent
T18	Condition 312 320;338 346	cellular crescent
T19	Multiplier 350 376	more than 25% of glomeruli
T21	Qualifier 379 382	CNS
T22	Condition 422 427	lupus
T23	Qualifier 399 418	organ manifestation
T24	Procedure 456 481	immunosuppressive therapy
T26	Drug 523 545	corticosteroid therapy
T27	Condition 552 558	asthma
T28	Condition 560 586	inflammatory bowel disease
T29	Condition 495 509	Co-morbidities
T31	Drug 605 617	prednisolone
T32	Drug 622 632	prednisone
T33	Drug 622 632;637 647	prednisone equivalent
T34	Multiplier 652 677	>20 mg/D for over 4 weeks
T35	Temporal 689 702	past 3 months
T37	Drug 720 723	MMF
T38	Multiplier 727 752	>1.5 g/D for over 4 weeks
T39	Temporal 764 777	past 3 months
T40	Condition 786 802	hypersensitivity
T41	Condition 806 820	intolerability
T42	Drug 824 836	prednisolone
T43	Drug 841 851	prednisone
T44	Drug 841 851;856 866	prednisone equivalent
T45	Drug 869 872	TAC
T46	Drug 877 880	MMF
T47	Multiplier 894 917	1.25 g or below per day
T50	Drug 963 966	TAC
T51	Drug 968 980	cyclosporine
T52	Drug 994 1015	calcineurin inhibitor
T53	Multiplier 1020 1032	over 4 weeks
T54	Temporal 1044 1059	past 12 months.
T56	Drug 1076 1092	cyclophosphamide
T57	Drug 1094 1105	leflunomide
T58	Drug 1110 1122	methotrexate
T59	Multiplier 1132 1139	2 weeks
T60	Procedure 1151 1167	biological agent
T61	Temporal 1206 1219	past 6 months
T64	Negation 1316 1323	allowed
T65	Drug 1240 1252	azathioprine
T66	Drug 1254 1264	mizoribine
T67	Drug 1278 1293	immunoglobulins
T68	Drug 1298 1312	anti-malarials
T70	Condition 1340 1352	hypertension
T71	Qualifier 1327 1339	Uncontrolled
T72	Measurement 1358 1369	systolic BP
T73	Measurement 1383 1395	diastolic BP
T74	Value 1370 1379	>160 mmHg
T75	Value 1396 1404	>95 mmHg
T77	Pregnancy_considerations 1407 1446	Women who are pregnant or breastfeeding
T78	Pregnancy_considerations 1449 1558	Women with childbearing potential or their male partners, who refuse to use an effective birth control method
